Related Articles
Alteration of smoking habit at time of first diagnosis influences survival of patients with HNSCC
Long‑responders to anti‑HER2 therapies: A case report and review of the literature
mRNA expression of specific HER ligands and their association with clinical outcome in patients with metastatic breast cancer treated with trastuzumab
Akt expression and compartmentalization in prediction of clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab
Phase II trial of dose-dense chemotherapy followed by dose-intense erlotinib for patients with newly diagnosed metastatic non-small cell lung cancer